Terns Pharmaceuticals (TERN) S-8 Registration of securities for employees

Exhibit 107

Calculation of Filing Fee Tables

Form S-8

(Form Type)

Terns Pharmaceuticals, Inc.

(Exact Name of Registrant as Specified in its Charter)

Table 1—Newly Registered Securities

Security Type	Security Class Title	Fee Calculation Rule	Amount Registered(1)	Proposed Maximum Offering Price Per Share(2)		Maximum Aggregate Offering Price		Fee Rate	Amount of Registration Fee
Equity	Common Stock, $0.0001 par value per share	457(c) and 457(h)	2,250,000 shares(3)		$7.08		$15,930,000	$153.10 per $1,000,000		$2,438.88
Total Offering Amounts							$15,930,000			$2,438.88
Total Fee Offsets										—
Net Fee Due										$2,438.88

(1) Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that becomes issuable under the 2022 Employment Inducement Award Plan, as amended (the “2022 Plan”), to prevent dilution by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock.

(2) Pursuant to 457(c) and 457(h) under the Securities Act, the proposed maximum offering price per share is estimated solely for the purpose of calculating the registration fee and is based upon the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Global Select Market on November 5, 2024, which date is within five business days prior to filing this Registration Statement.

(3) Represents 2,250,000 additional shares of the Registrant’s common stock under the Registrant’s 2022 Plan as a result of an increase approved by the compensation committee of the Registrant’s board of directors.